MOVIN Pilot Randomized Controlled Trial
MOVIN
Reproductive Mental Health of Ontario Virtual Intervention Network (MOVIN): A Pilot Randomized Controlled Trial
1 other identifier
interventional
101
1 country
1
Brief Summary
Despite available treatments for perinatal mood disorders, only 20% of affected women receive treatment that results in remission of symptoms. In order to address gaps in equitable access to treatment the investigators developed the Reproductive Mental health of Ontario Virtual Intervention Network (MOVIN), a virtual collaborative care platform to optimize access for pregnant and postpartum people in Ontario. MOVIN combines collaborative and stepped-care approaches to treatment of perinatal depression and anxiety. The overall objective of this pilot randomized controlled trial (RCT) is to determine the feasibility of implementing a protocol for studying MOVIN for pregnant and postpartum individuals with significant symptoms of depression and anxiety (EPDS \> 12) in order to inform the conduct of a larger scale evaluation. O will be randomized to either the MOVIN or control condition and will be asked to complete follow-up assessments 12- and 24-weeks post-randomization. Participants in the MOVIN arm will receive access to the MOVIN platform which includes a care coordinator to help them navigate various virtual treatments. Participants in the control condition will receive a resource list and will navigate the various options on their own.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2020
CompletedFirst Posted
Study publicly available on registry
December 23, 2020
CompletedStudy Start
First participant enrolled
April 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedMay 28, 2025
May 1, 2025
1.2 years
December 7, 2020
May 21, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Feasibility of the trial protocol: Recruitment
Measures of recruitment and retention include rate of recruitment, reason for non-participation and rate of completion of follow-up measures.
12 weeks post randomization
Feasibility of the trial protocol: Acceptability
Measures of acceptability include participants' overall experience and satisfaction with and acceptance of the MOVIN platform and the care coordinator, the care coordinator's assessment of the MOVIN platform and its impact on patient care, and primary care providers' assessment of MOVIN's impact on patient care.
12 weeks post randomization
Feasibility of the trial protocol: Compliance
Measures of compliance include rate of completion of MOVIN-specific activities, rate of completion of suggested interventions, and rate of resource use.
12 weeks post randomization
Secondary Outcomes (14)
Feasibility of the trial protocol: Recruitment
24 weeks post randomization
Feasibility of the trial protocol: Acceptability
24 weeks post randomization
Feasibility of the trial protocol: Compliance
24 weeks post randomization
Maternal clinical outcomes - depression symptoms
12 and 24 weeks post randomization
Maternal clinical outcomes - anxiety symptoms
12 and 24 weeks post randomization
- +9 more secondary outcomes
Other Outcomes (3)
Co-variates
Baseline
Maternal birth outcomes
Baseline, 12 and 24 weeks post randomization
Neonatal birth outcomes
Baseline, 12 and 24 weeks post randomization
Study Arms (2)
Enhanced Usual Care
OTHERAccess to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.
MOVIN
EXPERIMENTALEnhanced Usual Care plus MOVIN Care Platform. The MOVIN Care Platform is virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.
Interventions
A standardized handout with information on what treatment options might be useful to start with based on EPDS score and stage of pregnancy or postpartum.
Virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.
Eligibility Criteria
You may qualify if:
- Residents of Ontario at least 18 years of age
- Currently pregnant or mother\* of a live infant 0-12 months of age living at the same residence \*through natural birth, adoption or surrogacy, including cis women, non-binary and transgender people in all their diversity
- EPDS \> 12
- Registered with a primary care provider
You may not qualify if:
- Experiencing active suicidal ideation (MINI International Neuropsychiatric Interview)
- Active substance use disorder (GAIN-SS), current mania or psychosis (MINI Neuropsychiatric Interview)
- Unable to access the internet or a device that can support the MOVIN platform
- Unable to participate in English
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Women's College Hospital
Toronto, Ontario, M5S1B2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ariel Dalfen, MD
Women's College Hospital and Sinai Health System
- PRINCIPAL INVESTIGATOR
Simone Vigod, MD, MSc
Women's College Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Department of Psychiatry
Study Record Dates
First Submitted
December 7, 2020
First Posted
December 23, 2020
Study Start
April 12, 2021
Primary Completion
June 30, 2022
Study Completion
December 30, 2022
Last Updated
May 28, 2025
Record last verified: 2025-05